5PSQ-012 Prescription of dabigatran in the elderly population

BACKGROUND: Atrial fibrillation (AF) is a common clinical problem, particularly in the elderly. Dabigatran is indicated for the prevention of stroke and systemic embolism, and the reduction of vascular mortality for patients with non-valvular atrial AF. The recommended daily dose of dabigatran is 15...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Eur J Hosp Pharm
Päätekijät: López-Sepúlveda, R, Soto, C Valencia, Rodríguez-Hermida, F Artime, Gómez, P Nieto, Herrera, S Guijarro, Lirola, MA García, García, E Espínola, Barrera, J Cabeza
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Group 2018
Aiheet:
Section 5: Patient safety and quality assurance
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535149/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.366
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia